Larvol Delta - A-Phase-1-Study-to-Evaluate-CHM1101-CAR-T-Cells-in-Patients-With-MMP2-Recurrent-or-Progressive-Glioblastoma

CHM 1101 - Chimeric Therap

http://clinicaltrials.gov/ct2/show/NCT05627323

Nov 25, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next